ULTRASOUND - GUIDED FNAC REPORTING

ULTRASOUND - GUIDED FNAC REPORTING

Ultrasound
40% OFF

Ultrasound guided FNAC is a routine diagnostic procedure to evaluate lumps and growths. Under guidance , a thin hollow needle is inserted into a mass for sampling of cells. After appropriate staining, it is examined under a microscope to know about the type of the cells present. Ultrasound helps in the accurate placement of the needle.


Why is ULTRASOUND - GUIDED FNAC REPORTING done ?

It is used as a method for early detection of lymph node metastases in melanoma and other malignant conditions.

ULTRASOUND - GUIDED FNAC REPORTING Instructions

CCO:
No food intake for atleast 8 hours before the Ultrasound scan is done.BT,CT,APTT,CBC should be done prior to the test.

SLAs:
For Ultrasound test scheduled before 2 PM eConsultation will be scheduled before 9 PM same day and the physical reports to be delivered by 10 PM same day
For Ultrasound test scheduled after 2 PM eConsultation to start from 8 AM next day and the physical reports to be delivered starting from 8 AM next day

FACILITATOR:
Confirm the compliance of preparations required.

SLAs:
For Ultrasound test scheduled before 2 PM eConsultation will be scheduled before 9 PM same day and the physical reports to be delivered by 10 PM same day
For Ultrasound test scheduled after 2 PM eConsultation to start from 8 AM next day and the physical reports to be delivered starting from 8 AM next day

Why is ULTRASOUND - GUIDED FNAC REPORTING ?

The biopsy of breast lesions involves the collection of cells or tissue fragments that will be analyzed by a pathologist. There are different types depending on the method used to sample the lesion. One of them is fine-needle aspiration cytology (FNAC) which involves the collection of cells with a small-bore needle. Ultrasound FNAC is used to diagnose carcinomas of the breast has become increasingly widespread thanks to its many advantages -

  • It is a simple, low-cost procedure that can be performed rapidly
  • It is not associated with any serious complications or adverse effects and is well tolerated by most patients
  • It is highly efficient, providing a diagnosis in approximately 80�90% of all cases